Loading clinical trials...
Loading clinical trials...
Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department
The objective of this research study is to show superiority of intranasal dexmedetomidine to intranasal midazolam as anxiolysis prior to pediatric laceration repairs.
Age
1 - 5 years
Sex
ALL
Healthy Volunteers
No
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Start Date
June 1, 2014
Primary Completion Date
April 1, 2015
Completion Date
June 1, 2016
Last Updated
November 14, 2024
40
ACTUAL participants
Dexmedetomidine
DRUG
Midazolam
DRUG
Lead Sponsor
University of Pittsburgh
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions